MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    The potential role of Per- and Polyfluoroalkyl Substances (PFAS) in movement disorders: Implications and Risk assessment to Human Health

    N. Verma (Barotiwala, India)

    Objective: The objective of our study is to critically summarized the neurotoxicity of Perfluoroalkyl substances (PFAS) and linked this environmental pollutant with movement disorders and…
  • 2022 International Congress

    Genetic determinants of early motor progression in Parkinson’s cohorts

    A. Martinez-Carrasco, M. Lawton, R. Real, M. Tan, C. Carroll, JC. Corvol, D. Grosset, M. Hu, J. Hardy, N. Williams, Y. Ben-Shlomo, M. Shoai, H. Morris (London, United Kingdom)

    Objective: To determine the genetic determinants of motor progression in Parkinson disease (PD) using genome-wide analysis correlated with the MDS-UPDRS Part III motor scale. Background:…
  • 2022 International Congress

    Non-apoptotic caspase-3 activation mediates early synaptic dysfunction of indirect pathway neurons in the parkinsonian striatum

    C. Li, T. Fieblinger, E. Espa, MA. Cenci (Lund, Sweden)

    Objective: We set out to investigate whether caspase-3 plays a role in the loss of dendritic spines and the concomitant synaptic deficits that develop in…
  • 2022 International Congress

    Pallidal Deep Brain Stimulation for Treatment of Poststroke Hemichorea

    D. Yoo, CK. Park, TB. Ahn (Seoul, Republic of Korea)

    Objective: We report a case of medication-refractory poststroke hemichorea where deep brain stimulation of the globus pallidus internus (GPi-DBS) was utilized to alleviate hemichorea. Background:…
  • 2022 International Congress

    The distinctive functional connectivity of the cholinergic nucleus basalis of Meynert in Parkinson’s disease across different motor subtypes

    M. Nazmuddin, P. Zeidman, T. van Laar (Surabaya, Indonesia)

    Objective: We aim to compare the state of cortical-NBM functional connectivity across healthy control (HC), PIGD-predominant PD (PIGD-PD), and tremor-dominant PD (TD-PD). Additionally, the correlation…
  • 2022 International Congress

    Biochemical markers of glucocerebrosidase (GCase) deficiency in primary macrophages derived from GBA1 mutation carriers with and without Parkinson’s disease

    S. Pchelina, A. Kopytova, M. Nikolaev, A. Emelyanov, G. Baydakova, T. Usenko, A. Izymchenko, D. Bogdanova, K. Senkevich, I. Miliukhina, Y. Zakharova (Gatchina, Russian Federation)

    Objective: The aim of the present study was to assess biochemical markers in primary macrophages that could distinguish patient with Parkinson’s disease linked to mutations…
  • 2022 International Congress

    Blood Lipid Biomarkers in Early Parkinson Disease and Parkinson Disease with Mild Cognitive Impairment

    DX. Deng, LT. Tan (Singapore, Singapore)

    Objective: This study aims to investigate the association between comprehensive blood lipid biomarkers and Parkinson's disease (PD). Background: Studies have shown that the serum levels…
  • 2022 International Congress

    The Hidden Disease Burden and Treatment Experience of Patients with Essential Tremor: A Retrospective US Claims Analysis

    C. Vetterick, K. Lyons, R. Pendal, G. Belfort, B. Ravina (Boston, USA)

    Objective: To describe the attributes of patients with essential tremor (ET), associated comorbidities, and ET treatments using a US claims database. Background: ET is estimated…
  • 2022 International Congress

    Covid vaccine induced parkinsonism and cognitive dysfunction

    R. Dhamija, P. Talwar, S. Kushwaha, K. Gowdar (Delhi, India)

    Objective: To describe movement disorder and cognitive impairment in two patients following COVID-19 vaccination. Background: The manifestation of neurological complications have been increasingly evidenced following…
  • 2022 International Congress

    A novel alpha-synuclein gene (SNCA) missense variant in an Austrian familiy with atypical neuropathological features

    C. Brücke, M. Zech, T. Outeiro, E. Gelpi, A. Zimprich (VIenna, Austria)

    Objective: To offer clinical, genetic and neuropathological information in a novel alpha-synuclein gene (SNCA) missense variant to further our understanding of synucleinopathies. Background: Around 5–10% of…
  • « Previous Page
  • 1
  • …
  • 778
  • 779
  • 780
  • 781
  • 782
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley